Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized for You
we will pick new questions that match your level based on your Timer History
Track Your Progress
every week, we’ll send you an estimated GMAT score based on your performance
Practice Pays
we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Thank you for using the timer!
We noticed you are actually not timing your practice. Click the START button first next time you use the timer.
There are many benefits to timing your practice, including:
Have you ever wondered how to score a PERFECT 805 on the GMAT? Meet Julia, a banking professional who used the Target Test Prep course to achieve this incredible feat. Julia's story is nothing short of an inspiration.
Think a 100% GMAT Verbal score is out of your reach? Target Test Prep will make you think again! Our course uses techniques such as topical study and spaced repetition to maximize knowledge retention and make studying simple and fun.
GMAT Club 12 Days of Christmas is a 4th Annual GMAT Club Winter Competition based on solving questions. This is the Winter GMAT competition on GMAT Club with an amazing opportunity to win over $40,000 worth of prizes!
Join Manhattan Prep instructor Whitney Garner for a fun—and thorough—review of logic-based (non-math) problems, with a particular emphasis on Data Sufficiency and Two-Parts.
Here is the essential guide to securing scholarships as an MBA student! In this video, we explore the various types of scholarships available, including need-based and merit-based options.
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
95%
(hard)
Question Stats:
6%
(02:13)
correct
94%
(02:48)
wrong
based on 16
sessions
History
Date
Time
Result
Not Attempted Yet
Recently, the emergence of unintended and harmful side effects in many nascent, high-profile prescription drugs has resulted in a large increase in claims by drug companies against product liability insurance policies. This has caused product liability insurance premiums on projects that develop new prescription drugs to rise rapidly, which has led drug companies to try to extract more profits from existing, proven prescription drugs rather than trying to create new ones.
Which of the following, if true, taken together with the information above, best supports the conclusion that the cost of prescription drugs will continue to increase?
A: Since the risk of underwriting a drug-development project is spread over very few projects, premiums on these projects must be very high.
B: Whenever approved prescription drugs turn out to have unintended and harmful side effects, it is often very difficult to figure out which component of the drug's chemical formula has caused the side effect.
C: The higher the drug company's profit expectations are for a drug, the more it will be prescribed making it more likely that side effects will be revealed.
D: Most drug-development projects do not result in marketable drugs, so economies of scale in drug development are impossible to achieve.
E: Since many new drugs are developed by large, bureaucratic companies, inefficiencies in drug-development projects are unavoidable.
Archived Topic
Hi there,
This topic has been closed and archived due to inactivity or violation of community quality standards. No more replies are possible here.
Still interested in this question? Check out the "Best Topics" block below for a better discussion on this exact question, as well as several more related questions.
Recently, the emergence of unintended and harmful side effects in many nascent, high-profile prescription drugs has resulted in a large increase in claims by drug companies against product liability insurance policies. This has caused product liability insurance premiums on projects that develop new prescription drugs to rise rapidly, which has led drug companies to try to extract more profits from existing, proven prescription drugs rather than trying to create new ones.
Which of the following, if true, taken together with the information above, best supports the conclusion that the cost of prescription drugs will continue to increase?
A: Since the risk of underwriting a drug-development project is spread over very few projects, premiums on these projects must be very high.
B: Whenever approved prescription drugs turn out to have unintended and harmful side effects, it is often very difficult to figure out which component of the drug's chemical formula has caused the side effect.
C: The higher the drug company's profit expectations are for a drug, the more it will be prescribed making it more likely that side effects will be revealed.
D: Most drug-development projects do not result in marketable drugs, so economies of scale in drug development are impossible to achieve.
E: Since many new drugs are developed by large, bureaucratic companies, inefficiencies in drug-development projects are unavoidable.
Still interested in this question? Check out the "Best Topics" block above for a better discussion on this exact question, as well as several more related questions.